CM
SRNE

Caption Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Caption Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80,000
Closed -$547K – 1482
2020
Q4 		$547K Sell
80,000
-235,000
-75% -$1.89M 0.01% 723
2020
Q3 		$3.51M Buy
315,000
+215,000
+215% +$1.97M 0.08% 289
2020
Q2 		$628K Buy
+100,000
New +$383K 0.02% 635

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Caption Management's SRNE Position: Q1 2023 in Review

Caption Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 36,892 shares — an estimated $32.7K sold.

Caption Management first reported a position in SRNE in Q1 2020 and held it in 3 quarters. The position peaked at $150K in Q1 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Caption Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Caption Management sold 36,892 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $32.7K.
  • Caption Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 3 quarters.
  • Caption Management's Sorrento Therapeutics, Inc. position peaked at $150K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Caption Management's 13F filing for Q1 2023, filed 15 May 2023.